Introduction
Tumor initiation, growth, and propagation are frequently accompanied by desmoplasia and acquisition of a reactive stroma, mainly comprising leukocytes, fibroblasts, and endothelial cells [1] . The dynamic and reciprocal relationship between epithelial and mesenchymal compartments of the tumor dictates almost every aspect of cancer progression, even governing the efficacy of therapy and influencing the risk of disease relapse [2] . This epithelial-mesenchymal communication has been usually ascribed to a complex signaling network of growth factors and cytokines. Reactive oxygen species (ROS) have also been identified as potent modifiers of signaling pathways and consequently cell behavior. The balance between production of ROS and their elimination by antioxidants is important for tissue homeostasis [3, 4] . Microenvironmental oxidative stress conjures protective antioxidant response from tissues to regain homeostasis. However, ROS imbalance or the loss of homeostatic control in a continued oxidative microenvironment can either result in cell death caused by oxidative catastrophe or contribute to carcinogenesis, which are tissue-and context-dependent [5] [6] [7] . Indeed, ROS are byproducts of aberrant cancer cell metabolism and mitochondrial defects. However, little is known about the effect of tumor modulating ROS signals by fibroblasts, the most prominent cell type in tumor microenvironment.
Recent study showed that a deficiency in fibroblast peroxisome proliferator-activated receptor β/δ (PPARβ/δ) increased oxidative stress in wound microenvironment to delay keratinocyte migration [8] . PPARβ/δ has also been implicated in the pathogenesis of colorectal cancer (CRC). However, its role remains controversial as both pro-and anti-tumorigenic roles was reported from studies using conventional PPARβ/δ-knockout mice [9, 10] . On one hand, PPARβ/δ has been shown to exert potent protumorigenic effects. Early study suggested that nonsteroidal anti-inflammatory drugs (NSAIDs) reduced tumorigenesis through inhibition of PPARβ/δ [11] . PPARβ/δ has been shown to promote UV-induced skin tumorigenesis by upregulating Src expression and activity thereby enhancing the downstream EGFR/Erk1/2 pathway [12] . PPARβ/δ also enhanced CRC progression by regulating Glut1 and SLC10A5 expression, promoting cancer cell metabolic programming [13] . PPARβ/δ also promoted angiogenesis by stimulating the expression of VEGF in CRC and bladder cancer [14] [15] [16] . In addition, PPARβ/δ promoted a protumorigenic inflammatory environment through the increased production of COX-2-derived PGE 2 [16] . On the other hand, PPARβ/δ has also been reported to exert potent anti-inflammatory functions through interfering with the functions of transcription factors such as NFκB, AP1, STAT3 [17] . In melanoma, PPARβ/δ exhibited inhibitory effects on tumorigenicity via the modulation of inflammatory and apoptotic mechanisms [18] . In apparent discrepancies with earlier studies, several studies showed that NSAIDs increased PPARβ/δ expression in human CRC cell lines, suggesting that elevated PPARβ/δ level, rather than decreased level, contributed to the chemopreventive effects of NSAIDs. Using a tissue-specific approach to delineate the problem, subsequent studies using an intestinal epithelia-specific deletion and transgene overexpression of PPARβ/δ in mice supported a pro-tumorigenic role for epithelial PPARβ/δ [19, 20] . Recent work on skin squamous cell carcinoma showed that the expression of PPARβ/δ was reduced in cancer-associated fibroblasts [21] . Further investigation revealed that PPARβ/δ in cancer-associated fibroblasts reduced the invasiveness, xenobiotic resistance and cellular bioenergetics of the adjacent epithelial cancer, at least, in part via the secretion of growth factors and cytokines [21] . However, the role of fibroblast PPARβ/δ in the initiation and progression of CRC remains unclear.
Our understanding on the role of fibroblasts in pathologic conditions is hampered by the absence of specific markers. Fibroblast-specific protein (FSP)1 (or S100A-4) has been suggested as a fibroblast-specific marker in normal and fibrotic tissues. The intestinal mesenchyme comprises of a heterogeneous population of stromal cells of varying origins [22] . FSP1-directed deletion occurs in fibroblast subpopulation that had an active FSP1 promoter activity. Although FSP1 has been identified as a fibroblast marker and used for fibroblast depletion [23, 24] , the complete coverage of the entire fibroblast population by a single marker has proven to be tricky. Although FSP1 is only expressed in the mesenchymal lineage and commonly used for stromal-specific gene deletion strategy, it is lowly expressed if at all, in matured fibroblasts and myofibroblasts. Despite these limitations, FSP1 reporter mice and FSP1-Cre-driven gene deletion are considered reliable strategies to investigate fibroblast biology. Transgenic mice with green fluorescent protein expression driven by the FSP1 promoter have been used to map cell fate in fibroblast populations, and that FSP1-Cre animals have served as important tools to dissect the effects of fibroblast-specific gene deletion in fibrotic and neoplastic conditions. FSP1-directed deletion of genes, like Smoothened, PTEN, TGF receptor type II, and BMP receptor 2 in the fibroblasts have been used to study their roles in different tumor types such as acinar-ductal metaplasia, prostate, breast, and squamous cell carcinoma of the forestomach [25] [26] [27] [28] .
Drawing on the parallels between wound healing and cancer, we investigated the role of fibroblast PPARβ/δ in CRC. We generated a mouse whose PPARβ/δ gene was deleted in the fibroblasts (FSPCre-Pparb/d −/− ) by crossing a floxed PPARβ/δ mouse (Pparb/d fl/fl ) [29] with transgenic mice with a Cre transgene under the control of FSP1 promoter (FSP1-Cre) [30] . Fig. 1a ; Supplementary Fig. 1A-D) . Subsequent PCR and DNA gel analysis confirmed the deletion of exon 4 of PPARβ/δ gene has occurred in the intestinal fibroblasts, which were enriched in the locality of the stroma lamina propria region (Fig. 1b) (Fig. 1c, d ). The observed residual PPARβ/δ expression may be contributed by two technical difficulties. As mentioned above, FSP1 promoter is active in a subpopulation of fibroblasts. Although, the explant method is a reliable method to enrich and culture primary fibroblasts in vitro, it is also inevitable that other cell types such as endothelial cells and inflammatory immune cells from the stroma might have contaminated the culture [22, 31] . Importantly, our observation mirrored that in other studies where FSP1 promoter-driven gene deletion was targeted to the stroma of breast and pancreatic tissues [26, 30] . Ulcerative colitis and inflammatory bowel syndrome are common risk factors associated with CRC development [32, 33] . Well-established animal models for ulcerative colitis and inflammatory bowel syndrome have used DSS to induce colitis in mice, thus DSS was used to induce intestinal inflammation in two of the murine models. We investigated whether there were differences in the inflammatory processes that lead to tumor initiation. In DSSinduced colitis, the FSPCre-Pparb/d −/− mice yielded a lower disease activity index (DAI) ( Fig. 2a and Supplementary Table 2 ), reduced DSS-induced morphological aberrations and loss of the mucosa layer ( Fig. 3a-c) . Interestingly, our upstream regulator analyses of normal tumor adjacent and tumor epithelia revealed enhanced NRF2-mediated stress responses owing to the deletion of fibroblast PPARβ/δ (Fig. 3d, e) . NRF2 is a master regulator of antioxidant responses through binding to the antioxidant response elements in the gene's promoter region. It upregulates the expression of numerous antioxidant proteins to protect the cell from oxidative damages [34] . Available experimental evidence also clearly indicates that NRF2 is an important player in the maintenance of mitochondrial homeostasis and structural integrity (Holmstrom, Kostov et al. 2016 ). This role becomes particularly critical under conditions of oxidative, electrophilic, and inflammatory stress which influences the overall health and survival of the organism. The loss of NRF2 in mouse has been associated with increased susceptibility to CRC development [35] , underscoring NRF2 as a potential chemopreventive target [36] . PPARs have been implicated as one of the downstream mediators of NRF2 [37] . For example, functional PPAR response element has been identified in the glutathione S-transferase [38, 39] , glutathione peroxidase 1, and catalase genes [8] . PPARβ/δ has also been shown to exert antioxidant effect on cardiomyocytes by inhibiting PI3K/Akt signaling pathway to suppress ROS generation induced by AngII, however very little is known about its role in redox regulation in the gut [40] [41] [42] . Therefore, we winnowed our attention on NRF2 and associated antioxidant genes in the colon of FSPCre-Pparb/d
We observed an increase in NRF2 expression, concomitant with elevated expression of antioxidant enzymes in intact FSPCre-Pparb/d −/− colons (Fig. 3f) . We also found higher expression of antioxidant (e.g., glutathione peroxidase and catalase) genes in the FSPCre-Pparb/d (Fig. 3g) . This was supported by increased NRF2 staining in the intestinal villi, as well as increased nuclear NRF2 protein in FSPCre- (Fig. 3h-i) . Indeed, Therefore, our data provides evidence that NRF2 and its downstream oxidative stress signaling pathways were elevated in FSPCre-Pparb/d
−/− colons and may be a major contributing factor for the reduced CRC in these mutant mice.
PPARβ/δ deficiency in fibroblasts lowers oxidative stress in HCT116, HT29, and iCEC cells colons have more of the anti-inflammatory M2 macrophages, but higher M1 macrophages upon DSS treatment ( Supplementary Fig. 2D ). The lower M1:M2 ratio in FSPCre-Pparb/d −/− colon was consistent with the reduced inflammatory cytokine landscape. Clinical and experimental evidence have indicated that inflammatory milieu and elevated ROS contribute to cancer initiation [45, 46] . ROS production is usually associated with the activation and functions of M1 rather than M2 macrophages. Together, they suggest that immune cells have minor role in tumor initiation of FSPCre-Pparb/d −/− mice.
Previous study reported that PPARβ/δ in wound fibroblasts transcriptionally regulates the expression of H 2 O 2 -detoxifying enzymes, glutathione peroxidase 1 and catalase, culminating in reduced ROS in the wound microenvironment [8] . Indeed, we detected elevated extracellular H 2 O 2 in the conditioned medium of PPARβ/δ-deficient fibroblasts compared to their wild-type counterparts (Fig. 4c) . No significant difference in intracellular H 2 O 2 levels in the fibroblasts (Fig. 4d, e) . Explanted FSPCre-Pparb/d −/− fibroblasts also have overall reduction in the expression antioxidant genes (8 of 12 genes), suggesting a more oxidative phenotype that contributed to the elevated H 2 O 2 production and secretion into the microenvironment (Fig.  4f) . Numerous studies have showed that the activation of cytoprotective NRF2-mediated stress responsive genes in response to elevated oxidative stress, like extracellular H 2 O 2 . Thus, to strengthen our observation that the novel epithelial-mesenchymal communication in oxidative stress homeostasis was dysregulated in FSPCre-Pparb/d −/− , as well as a direct effect of fibroblast PPARβ/δ on the oxidative status of adjacent epithelia, we measured ROS in two different human intestinal cancer cell lines (HCT116 and HT29) co-cultured with either PPARβ/δ-deficient fibroblasts or in conditioned media from FSPCre-Pparb/d
and Pparb/d −/− colonic fibroblasts (Fig. 4g-o) . Consistent with our gene expression data, we detected higher expression of NRF2 and associated antioxidant enzymes in HCT116 and HT29 cultured in conditioned media from FSPCre-Pparb/d −/− than in PPARb/d fl/fl colonic fibroblasts (Fig. 4g, h ). This is coupled with reduced ROS levels in growth factors, has been shown to exert transformative and growth-promoting effects on epithelial cells [47] . We observed an increase in HCT116 cells at either G2/M or S phase when was co-cultured with PPARβ/δ-knockdown fibroblast cell lines compared with cognate controls (Supplementary Figure 2H ).
Our findings suggest that an elevated NRF2-related response in the colon epithelia was associated with reduced CRC. Thus, we explore the effect of NAC pre-treatment on CRC initiation in DSS-treated APC (Fig. 1n) . Although the precise reason for this observation is unclear, we speculate that additional reduction in epithelial ROS might have disrupted critical ROS-mediated cellular functions necessary for homeostasis in APC min/+ FSPCre-Pparb/d −/− mice, which already have elevated NRF2 antioxidant response. Studies from the past two decades have established that ROS serve as signaling molecules to regulate biological and physiological processes [48] . Clearly, future experiments will be necessary to understand the effect of antioxidant treatment on normal cellular functions in FSPCre-Pparb/d −/− mice, as well as the optimal antioxidant treatment regime to reduce CRC in wild-type mice. We showed a major role for stromal PPARβ/δ in ROS production that consequently conjures an NRF2-mediated antioxidant response, reducing ROS levels in the adjacent intestinal epithelial cancer cells. NRF2-mediated response also results in the activation of various signaling pathways that facilitates tumor cell senescence [49, 50] . Collectively, we propose that FSPCre-Pparb/d −/− colonic epithelium are subjected to a constant dose of ROS, extracellular H 2 O 2 from their neighboring stroma, which triggers NRF2-mediated signaling that suppresses tumor development.
Conclusion
Our data have shown that PPARβ/δ ablation in fibroblasts results in reduced tumorigenesis across three different mice models of CRC. Microarray gene expression and gene Nuclear receptor PPARβ/δ has been implicated in CRC, although it remained controversial as studies have shown supporting evidence for PPARβ/δ playing an antitumorigenic [16] and pro-tumorigenic roles in CRC [51] . It is conceivable that PPARβ/δ has dual roles in tumorigenesis, much like TGF-β1 and ROS. By regulating cell growth, death, and immortalization, TGFβ signaling pathways exert tumor suppressor effects in normal cells and early carcinomas. But as tumors progress, these protective and cytostatic effects of TGFβ are often lost, switching to promote cancer progression, invasion, and tumor metastasis. Similarly, chronic oxidative stress has been shown to promote tumorigenesis [47, 52] , whereas the modulation of oxidative stress as an anticancer therapeutic agent has also been discussed [53] . With the temporal and dose-dependent basis of oxidative stress on tumor formation and development, this may explain the dual effect of PPARβ/δ on tumorigenesis.
Limitations of our study include that one genetic background of mouse and our deletion strategy consists of the deletion of exons coding for the DNA-binding domain of PPARβ/δ. Different mouse strains may exhibit different susceptibility to carcinogen or tolerance to oxidative stress. It is also conceivable that other gene deletion strategies may result in different phenotypic severity or outcomes owing to differences in vulnerabilities to the oxidative stress. FSP1 is a key marker of a specific subset of macrophages in the liver during fibrosis and injury [54] , although no report has described confounding issues in other organs. Nevertheless, to the best of our knowledge, this is the first study to examine the role of fibroblast PPARβ/δ in CRC, which reveals novel epithelial-mesenchymal communication in ROS homeostasis. Our results illustrate that PPARβ/δ modulation of oxidative stress has potential medical applicability. −/− colons. Total RNA was extracted, and RTqPCR was performed as described in legends of Fig. 1d , e. were Ribosomal 18S rRNA served as a housekeeping gene. Data are represented as mean ± S.E.M. from 4 independent experiments. * p < 0.05, ** p < 0.01. g, h, k, n Relative fold change in mRNA levels of 13 genes associated with oxidative stress response in HCT116 (g, k, n) and HT29 cells (h) cultured in conditioned medium of fibroblasts from 18 S rRNA served as housekeeping gene. Data are represented as mean ± S.E.M. from four independent experiments. * P < 0.05, ** P < 0.01
